Sibel Dogan-Gunaydin

12PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersNutritional epidemiologyPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pacific Peoples psychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 27, 2025
Early response is a strong predictor of the long-term response in psoriasis patients receiving risankizumab or guselkumab in the real-world: a retrospective analysis.

Neslihan Akdogan, Ömer Kutay Mutlu, Erdem Karabulut

|Jan 08, 2025
The Impact of Diet on Hidradenitis Suppurativa Severity: A Cross-Sectional Case-Control Study.

Ferhan Kesik, Sibel Dogan-Gunaydin, Mehmet Fisunoglu

|Jul 12, 2024
Psoriatic arthritis, biologic therapy experience, body mass index, and onset age of psoriasis were independent factors of secukinumab discontinuation in patients with psoriasis.

Neslihan Akdogan, Kerem Balan, Basak Yalici Armagan

|Oct 05, 2021
Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real-life data from a single centre.

Leyla Huseynova Terzi, Neslihan Akdogan, Sibel Dogan Gunaydin

|Sep 14, 2021
Age and psoriatic arthritis are important predictors of biologic agent switch in psoriasis.

Neslihan Akdogan, Sibel Dogan, Ecem Bostan

|Jun 18, 2019
Association of serum cortisol and dehydroepiandrosterone sulfate (DHEAS) levels with psychological stress in patients with vitiligo

Ahmet Gürpınar, Sibel Doğan Günaydın, Cengiz Kılıç

Pageof 2

Frequent Collaborators

8 joint publications

Neslihan Akdogan

5 joint publications

Başak Yalıcı Armağan

3 joint publications

Nilgun Atakan

2 joint publications

Ecem Bostan